ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 973,03
-0,43%
Dow Jones
44 303,40
-0,99%
DAX
21 787,00
-0,58%
Brent Oil
74,565
0,00%
Bitcoin
96 223,10
-0,33%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. DelMar Pharmaceuticals Inc (DMPI) Cours

DelMar Pharmaceuticals Inc

DelMar Pharmaceuticals Inc (DMPI)

NASDAQ
1,34
0,00
(0,00%)
Fermé 08 Février 10:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
1,34
Prix Achat
1,32
Prix Vente
1,34
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
74,109M
Clôture Veille
1,34
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
55 305 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-27,91
Bénéfice par action (BPA)
-0,15
Chiffre d'affairess
-
Bénéfice net
-8,5M

À propos de DelMar Pharmaceuticals Inc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.kintara.com
Siège social
Reno, Nevada, USA
Fondé
-

DMPI Dernières nouvelles

Plus de nouvelles

DelMar Announces $19.6 Million Private Placement Priced At-The-Market

DelMar Announces $19.6 Million Private Placement Priced At-The-Market PR Newswire SAN DIEGO, Aug. 18, 2020 SAN DIEGO, Aug. 18, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI...

18 Août 2020
PR Newswire (US)

DelMar Announces Approval of Merger by Stockholders

DelMar Announces Approval of Merger by Stockholders PR Newswire SAN DIEGO, Aug. 17, 2020 SAN DIEGO, Aug. 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the...

17 Août 2020
PR Newswire (US)

DelMar Pharmaceuticals to Host Conference Call to Discuss Proposed Acquisition of Adgero Pharmaceuticals

DelMar Pharmaceuticals to Host Conference Call to Discuss Proposed Acquisition of Adgero Pharmaceuticals Conference Call to be held Thursday, July 23, 2020 at 4:30pm ET PR Newswire SAN DIEGO...

17 Juillet 2020
PR Newswire (US)

DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Resear...

DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083's Participation in a Pivotal Study for...

24 Juin 2020
PR Newswire (US)

DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed an...

DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II Findings Support...

22 Juin 2020
PR Newswire (US)

DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline

DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline Combination creates a diversified biopharmaceutical company with a robust product pipeline targeting rare, unmet...

10 Juin 2020
PR Newswire (US)

Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals' VAL-083 to Participate in the GBM AGILE Pivotal...

Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals' VAL-083 to Participate in the GBM AGILE Pivotal Study, an Adaptive Clinical Trial Platform in Glioblastoma...

04 Juin 2020
PR Newswire (US)

DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Canc...

DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Cancer Research Virtual Annual Meeting II PR Newswire SAN DIEGO, June 1...

01 Juin 2020
PR Newswire (US)

DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate Updates

DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate Updates PR Newswire SAN DIEGO, May 13, 2020 SAN DIEGO, May 13, 2020 /PRNewswire/ -- DelMar...

13 Mai 2020
PR Newswire (US)

DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment o...

DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment of Brain Tumors Phase 2 trial more than 90% enrolled with enrollment...

05 Mai 2020
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

DMPI - Frequently Asked Questions (FAQ)

What is the current DelMar Pharmaceuticals share price?
The current share price of DelMar Pharmaceuticals is US$ 1,34
How many DelMar Pharmaceuticals shares are in issue?
DelMar Pharmaceuticals has 55 305 000 shares in issue
What is the market cap of DelMar Pharmaceuticals?
The market capitalisation of DelMar Pharmaceuticals is USD 74,11M
What is the 1 year trading range for DelMar Pharmaceuticals share price?
DelMar Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of DelMar Pharmaceuticals?
The price to earnings ratio of DelMar Pharmaceuticals is -27,91
What is the reporting currency for DelMar Pharmaceuticals?
DelMar Pharmaceuticals reports financial results in USD
What is the latest annual profit for DelMar Pharmaceuticals?
The latest annual profit of DelMar Pharmaceuticals is USD -8,5M
What is the registered address of DelMar Pharmaceuticals?
The registered address for DelMar Pharmaceuticals is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501
What is the DelMar Pharmaceuticals website address?
The website address for DelMar Pharmaceuticals is www.kintara.com
Which industry sector does DelMar Pharmaceuticals operate in?
DelMar Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
CDTConduit Pharmaceuticals Inc
US$ 2,831
(82,65%)
144,17M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
TOIIWOncology Institute Inc
US$ 0,033
(58,88%)
7,27k
CYTHCyclo Therapeutics Inc
US$ 1,19
(54,55%)
84,73M
FTELFitell Corporation
US$ 2,70
(-57,01%)
2,3M
SGBXSafe and Green Holdings Corporation
US$ 0,6401
(-44,82%)
5,65M
NKLANikola Corporation
US$ 0,4432
(-41,10%)
52,44M
PLRXPliant Therapeutics Inc
US$ 7,785
(-34,85%)
6,44M
LIPOLipella Pharmaceuticals Inc
US$ 3,08
(-33,76%)
2,2M
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
RIMEAlgorhythm Holdings Inc
US$ 0,0169
(-20,66%)
274,2M
NVDANVIDIA Corporation
US$ 129,84
(0,90%)
228,2M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0537
(14,74%)
212,29M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
DMPI
DelMar Pharmaceuticals
LSE
69NR
Anz Bank 43
BIT
UB514T
Unicredit Bank
BIT
S31829
Societe Generale Effekten
BIT
NSCIT0013325
Republic of France
BIT
S29566
Societe Generale Effekten
BIT
F23299
Vontobel Financial Produ...
BIT
UC8E5R
Unicredit Bank
BIT
3SCO
Graniteshares 3x Short C...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces